1-8 of 8
Yael Morgenstern
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Extramedullary disease in AML: A high-risk feature beyond ELN 2022 classification

Free
Yael Morgenstern, Claire Andrews, Eshetu Atenafu, Steven Chan, Vikas Gupta, Mark Minden, Dawn Maze, Aaron Schimmer, Andre Schuh, Karen W.L. Yee, Hassan Sibai
Journal: Blood
Blood (2025) 146 (Supplement 1): 3388.
https://doi.org/10.1182/blood-2025-3388
Published: 2025
Journal Articles

DNA methylation instability as a biomarker to predict resistance or progression to advanced disease Phase following tyrosine kinase inhibitor therapy in chronic myeloid leukemia

Free
Yael Morgenstern, Oyeronke Ayansola, Jae-Sook Ahn, Maria Perusini, Flavia Patino, Danielle Pyne, Amirthagowri Ambalavanan, Hyeoung-Joon Kim, Dennis Kim
Journal: Blood
Blood (2025) 146 (Supplement 1): 7274.
https://doi.org/10.1182/blood-2025-7274
Published: 2025
Journal Articles

Feasibility of the edmonton symptom assessment system (ESAS) score as patient-reported outcomes (PROs) assessment in chronic myeloid leukemia patients receiving tyrosine kinase inhibitor therapy: A pilot Study

Free
Maria Perusini, Noora Obaidallah, Yael Morgenstern, Flavia Patino, Dennis Kim
Journal: Blood
Blood (2025) 146 (Supplement 1): 7294.
https://doi.org/10.1182/blood-2025-7294
Published: 2025
Journal Articles

Immune deconvolution from whole transcriptomic data suggests expansion of exhausted T-cells and natural killer cells following tyrosine kinase inhibitor therapy in chronic myeloid leukemia patients

Free
Yael Morgenstern, Amirthagowri Ambalavanan, Jae-Sook Ahn, Maria Perusini, Flavia Patino, Danielle Pyne, Oyeronke Ayansola, Hyeoung-Joon Kim, Dennis Kim
Journal: Blood
Blood (2025) 146 (Supplement 1): 1991.
https://doi.org/10.1182/blood-2025-1991
Published: 2025
Journal Articles

Real-world data comparison of asciminib 40 mg twice daily vs. 80 mg once daily in chronic myeloid leukemia patients

Free
Ana Patiño, Yael Morgenstern, Noora Obaidallah, Maria Perusini, Dennis Kim
Journal: Blood
Blood (2025) 146 (Supplement 1): 7300.
https://doi.org/10.1182/blood-2025-7300
Published: 2025
Journal Articles

Emergence of new somatic mutations in CML patients optimally responding to tyrosine kinase inhibitor therapy: Proposal of long-term genomic monitoring

Free
Yael Morgenstern, Gopila Gupta, Flavia Patino, Maria Perusini, Daniela Zackova, Ivana Jeziskova, Anezka Kvetkova, Tomas Jurcek, Azin Keshavarz, Danielle Pyne, Oyeronke Ayansola, Amirthagowri Ambalavanan, Jiri Mayer, Andrea Arruda, Mark Minden, Jessie Medeiros, Sagi Abelson, Dennis Kim
Journal: Blood
Blood (2025) 146 (Supplement 1): 3767.
https://doi.org/10.1182/blood-2025-3767
Published: 2025
Journal Articles

AML Drug Tolerant Persister (DTP) Cells Survive Chemotherapy By Transiently Altering Cellular Lipidomics to Increase Plasma Membrane Rigidity, but Also Increases Sensitivity to Immune Cell Killing

Free
Yael Morgenstern, JongBok Lee, Yoosu Na, William Gwynne, Rose Hurren, Li Ma, Marcela Gronda, Chaitra Sarathy, Arvind Mer, Andrea Arruda, Avraham Frisch, Tsila Zuckerman, Yishai Ofran, Mark D. Minden, Li Zhang, Catherine O'Brien, J. Rafael Montenegro-Burke, Aaron D. Schimmer
Journal: Blood
Blood (2023) 142 (Supplement 1): 2806.
https://doi.org/10.1182/blood-2023-178995
Published: 2023
Journal Articles

The Contribution of Bone Marrow Stromal Cells to Leukemia Evolution: Differential Support of Leukemia Cell Growth at Diagnosis and Remission

Free
Shlomit Yehudai-Reshef, PhD, Shira Attias, Tal Gabay, Rawan Sabah, Yael Morgenstern, MD PhD, Tsila Zuckerman, MD
Journal: Blood
Blood (2015) 126 (23): 5419.
https://doi.org/10.1182/blood.V126.23.5419.5419
Published: 2015